Kelly Thai: Q3 2024 Report

SZSIOct 24 00:00 · Announcements

shanghai kinetic medical (300326.SZ): Currently there are no similar allogeneic bone-related products.

On September 12, Kailitai (300326.SZ) stated on the investor interaction platform that the company currently does not have related products of the same kind of allogeneic bone. The company's main implant products include spinal internal fixation products, bone cement, and vertebral body fusion devices. The main raw materials for spinal internal fixation products are pure titanium or titanium alloy, the main component of bone cement is polymethyl methacrylate, and the main material of vertebral body fusion devices is polyetheretherketone copper.

Gelonghui FinanceSep 12 16:57

Kelly Thai: 2024 Semi-Annual Report

SZSIAug 28 00:00 · Announcements

Kelly Tai: 2024 Semi-Annual Report Summary

SZSIAug 28 00:00 · Announcements

Shanghai Kinetic Medical (300326.SZ): Net income in the first half of the year was 30.238 million yuan, a year-on-year decrease of 73.64%.

Shanghai Kinetic Medical (300326.SZ) released its interim report for the first half of 2024. During the reporting period, the company's revenue was 0.476 billion yuan, a year-on-year decrease of 8.96%. The net income attributable to shareholders of the listed company was 30.238 million yuan, a year-on-year decrease of 73.64%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 24.9249 million yuan, a year-on-year decrease of 64.08%. The basic earnings per share were 0.0422 yuan per share.

Gelonghui FinanceAug 27 21:28

Shanghai Kinetic Medical (300326.SZ) announced its performance for the first half of the year, with a net income of 30.238 million yuan, a year-on-year decrease of 73.64%.

Shanghai Kinetic Medical (300326.SZ) released its 2024 semi-annual report, with a revenue of 0.476 billion yuan, an increase of...

Zhitong FinanceAug 27 20:11